Skip to main content

Israel Molina Romero

Sóc metge i responsable de la Unitat de Medicina Tropical i Salut Internacional

Institutions of which they are part

Head of group
Infectious Diseases
Vall Hebron Institut de Recerca
Infectious Diseases
General Hospital

Israel Molina Romero

Institutions of which they are part

Head of group
Infectious Diseases
Vall Hebron Institut de Recerca
Infectious Diseases
General Hospital

Sóc metge i responsable de la Unitat de Medicina Tropical i Salut Internacional

Llicenciat en Medicina per la UAB. Adjunt del Servei de Malalties Infeccioses Hospital Universitari Vall d'Hebron. Responsable de la Unitat de Medicina Tropical i Salut Internacional de l'Hospital Vall d'Hebron. Director del Programa de Salut Internacional de l'ICS. Experiència clínica i de recerca a Guinea Ecuatorial, Brasil i Angola.

Projects

Benznidazol and Triazol REsearch group for Nanomedicine and Innovation on Chagas disease (BERENICE) Grant Agreement nº 305937

IP: Israel Molina Romero
Collaborators: Maria Luisa Aznar Ruiz de Alegria, Núria Pérez Picazo, Fernando M Salvador Velez, Tamara Del Rio Higueras, Adrián Sánchez Montalvá, Elena Sulleiro Igual, Olga Sánchez- Maroto Carrizo, Janna Anthonina Slabbekoorn, Esperanza Esteban Serna
Funding agency: EUROPEAN COMMISSION
Funding: 939958.88
Reference: BERENICE_FP7HEALTH2012
Duration: 01/09/2012 - 31/08/2018

Estudio prospectivo para el cribado de la infección tuberculosa latente en población inmigrante mediante la prueba de la tuberculina y Quantiferon

IP: Israel Molina Romero
Collaborators: Jose Angel Rodrigo Pendás, Begoña Treviño Maruri, Fernando M Salvador Velez, Mª Teresa Tórtola Fernández, Adrián Sánchez Montalvá
Funding agency: Instituto de Salud Carlos III
Funding: 35392.5
Reference: PI11/01503
Duration: 01/01/2012 - 30/06/2016

iNTER Support Action (International Network of Teleconsultation Excellence & Referral (iSA) Grant Agreement nº 223610

IP: Israel Molina Romero
Collaborators: Vicenç Falcó Ferrer
Funding agency: EUROPEAN COMMISSION
Funding: 33590
Reference: ISA 223610 FP7 HEALTH 2007
Duration: 01/09/2009 - 29/02/2012

Protocolo de ensayo clínico de fase II, aleatorizado y abierto para el tratamiento etiológico de la enfermedad de chagas crónica con posaconazol y benznidazol

IP: Albert Pahissa Berga
Collaborators: Maria Antònia Agustí Escasany, Israel Molina Romero, Inmaculada Fuentes Camps, Fernando M Salvador Velez, Jordi Gómez i Prat, Elena Sulleiro Igual
Funding agency: Ministerio Sanidad
Funding: 360687.3
Reference: TRA-201
Duration: 01/01/2010 - 31/12/2013

Related news

This project will make societies aware of their rights related to sexual and reproductive health and empower young people to make informed and appropriate choices.

The new protocol has the same efficacy as the standard one, but only a quarter of the duration, reducing dropout rates and side effects.

The initiative, carried out at the Consulate of Bolivia, has resulted in 307 new tests for the diagnosis of Chagas disease

Related professionals

Bruno García del Blanco

Bruno García del Blanco

Main researcher
Cardiovascular Diseases
Read more
Jordi Pradell Teigell

Jordi Pradell Teigell

General Surgery
Read more
Mercè Beltran Vilagrasa

Mercè Beltran Vilagrasa

Main researcher
Read more
Marc Ribó Jacobi

Marc Ribó Jacobi

Main researcher
Stroke research
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.